Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals

Sharon B. Mannheimer, Nicholas Wold, Edward M. Gardner, Edward E. Telzak, Katherine Huppler Hullsiek, Margaret Chesney, Albert W. Wu, Rodger David MacArthur, John Matts, Gerald Friedland

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Symptoms and quality of life were assessed among human immunodeficiency virus (HIV)-infected individuals initiating their first course of antiretroviral therapy. Symptoms, which were mostly mild or moderate, were common in the first year and significantly affected the patients' quality of life. Quality of life was inversely related to the number of symptoms and in the change in the number of symptoms from baseline.

Original languageEnglish (US)
Pages (from-to)941-945
Number of pages5
JournalClinical Infectious Diseases
Volume46
Issue number6
DOIs
StatePublished - Mar 15 2008

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals'. Together they form a unique fingerprint.

  • Cite this

    Mannheimer, S. B., Wold, N., Gardner, E. M., Telzak, E. E., Hullsiek, K. H., Chesney, M., Wu, A. W., MacArthur, R. D., Matts, J., & Friedland, G. (2008). Mild-to-moderate symptoms during the first year of antiretroviral therapy worsen quality of life in HIV-infected individuals. Clinical Infectious Diseases, 46(6), 941-945. https://doi.org/10.1086/528859